NCT01069523View on ClinicalTrials.gov

Electrophysiological Effects of Guanfacine Extended Release in Attention Deficit Hyperactivity Disorder (ADHD)

PHASE4CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
Attention Deficit Disorder With Hyperactivity
Interventions
DRUG

Guanfacine Extended Release

Guanfacine is an alpha-2A agonist which is given one a day. the dose range is 1-4 mg. It is a tablet.

DRUG

Placebo

Table that match the 1 mg Guanfacine Extended Release Tablet. They are dosed once a day.

Trial Locations (1)

78229-3900

Dept. Of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio

Sponsors

Collaborators (1)

Shire
All Listed Sponsors
collaborator

Shire

INDUSTRY

lead

The University of Texas Health Science Center at San Antonio

OTHER